Inventor · disambiguated record
Matthew Manning Riggs
Also filed as: RIGGS MATTHEW MANNING
2 granted patents·6 pending applications·3 citations·filing 2017–2024
45Inventor score
Files withMEREO BIOPHARMA 3 LTD8
Top patents by PatentIndex Score
8 records- 0178US10961305B2Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfectaMEREO BIOPHARMA 3 LTD·Filed 2017·Granted Mar 30, 2021·3 cites·19 claims
- 0274US2024400666A1Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfectaMEREO BIOPHARMA 3 LTD·Filed 2024·Application pending·0 cites
- 0371US2023365669A1Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfectaMEREO BIOPHARMA 3 LTD·Filed 2023·Application pending·0 cites
- 0469US2025122273A1Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfectaMEREO BIOPHARMA 3 LTD·Filed 2024·Application pending·0 cites
- 0561US2021253684A1Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfectaMEREO BIOPHARMA 3 LTD·Filed 2020·Application pending·0 cites
- 0659US12173058B2Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfectaMEREO BIOPHARMA 3 LTD·Filed 2021·Granted Dec 24, 2024·0 cites·11 claims
- 0757US2020123242A1Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfectaMEREO BIOPHARMA 3 LTD·Filed 2020·Application pending·0 cites
- 0852US2020179509A1Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfectaMEREO BIOPHARMA 3 LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthew Manning Riggs files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →